Gastric body carcinoma

Summary

Gastric body carcinoma (MONDO:0003972) is a cancer. A subtype of gastric carcinoma — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Classification: Cancer

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	gastric body carcinoma
Mondo ID	MONDO:0003972
DOID	DOID:6705
NCIT	C8399
SNOMED CT	254557000
UMLS	C0345804
MedGen	87515
GARD	0027660
Anatomy (UBERON)	UBERON:0001161
Is cancer (heuristic)	yes

Also known as: body of stomach carcinoma · cancer of body of stomach · cancer of gastric body · cancer of the body of the stomach · cancer of the gastric body · carcinoma of body of stomach · carcinoma of gastric body · carcinoma of the body of the stomach · carcinoma of the gastric body · gastric body (stomach) cancer · gastric body cancer · gastric body carcinoma

Disease family

This is a subtype of gastric carcinoma. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › digestive system disorder › digestive system cancer › gastric cancer › gastric carcinoma › gastric body carcinoma

Related subtypes (11): gastric cardia carcinoma, gastric fundus carcinoma, gastric pylorus carcinoma, stomach carcinoma in situ, gastric adenocarcinoma, gastric small cell neuroendocrine carcinoma, gastric squamous cell carcinoma, Epstein-Barr virus-associated gastric carcinoma, hereditary gastric cancer, carcinoma of stomach, salivary gland type, undifferentiated carcinoma of stomach

Subtypes (1): carcinoma in situ of gastric body

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.